139 related articles for article (PubMed ID: 4627535)
1. [Influence of extracellular calcium concentration on the effect of coronary dilatators (action mechanism of coronary dilatators)].
Kosche F; Raff KW; Lochner W
Pflugers Arch; 1972; 335(1):46-57. PubMed ID: 4627535
[No Abstract] [Full Text] [Related]
2. Quantitative and comparative studies of pharmacological features in the coronary, femoral and renal circulations with different coronary vasodilators.
Oguro K; Hashimoto K
Jpn J Pharmacol; 1974 Apr; 24(2):227-33. PubMed ID: 4212295
[No Abstract] [Full Text] [Related]
3. Effects of various coronary vasodilators on myocardial oxygen consumption.
Oguro K; Kubota K; Kimura T; Hashimoto K
Jpn J Pharmacol; 1973 Aug; 23(4):459-66. PubMed ID: 4202125
[No Abstract] [Full Text] [Related]
4. Effect of nitrates and other coronary dilators on large and small coronary vessels: an hypothesis for the mechanism of action of nitrates.
Winbury MM; Howe BB; Hefner MA
J Pharmacol Exp Ther; 1969 Jul; 168(1):70-95. PubMed ID: 4978326
[No Abstract] [Full Text] [Related]
5. Cardiohemodynamic effects of nitroglycerin and several vasodilators.
Kokubun M; Taira N; Hashimoto K
Jpn Heart J; 1974 Mar; 15(2):126-44. PubMed ID: 4209772
[No Abstract] [Full Text] [Related]
6. [The mechanism of coronary dilatating action of nifedipine].
Kosche F; Raff WK; Lochner W
Arzneimittelforschung; 1972 Jan; 22(1):39-42. PubMed ID: 5066996
[No Abstract] [Full Text] [Related]
7. [Is adenosine the mediator for the regulation of the coronary circulation and for the effect of coronarodilators? Review].
Meisel M; Meisel P
Pharmazie; 1974 Sep; 29(9):361-8. PubMed ID: 4213610
[No Abstract] [Full Text] [Related]
8. [On the method of action of new types of coronary dilatators with simultaneous oxygen-saving myocardial effects, prenylamine and iproveratril. 2].
Fleckenstein A; Kammermeier H; Döring HJ; Freund HJ
Z Kreislaufforsch; 1967 Aug; 56(8):839-58. PubMed ID: 5592708
[No Abstract] [Full Text] [Related]
9. [Animal experiment study on the coronary and circulatory effect of dipyridamole, carbocromen, hexobendine, dilazep and glucagon].
Reploh HD
Arzneimittelforschung; 1973 May; 23(5):629-39. PubMed ID: 4740201
[No Abstract] [Full Text] [Related]
10. Drug-induced changes in cardiac energy.
Fleckenstein A
Adv Cardiol; 1974; 12(0):183-97. PubMed ID: 4600368
[No Abstract] [Full Text] [Related]
11. [Studies on nifedipine, a coronary vasodilator agent with rapid sublingual effects].
Raff WK; Kosche F; Lochner W
Arzneimittelforschung; 1972 Jan; 22(1):33-9. PubMed ID: 5066995
[No Abstract] [Full Text] [Related]
12. [BAY a 1040--a highly potent Ca ++ -antagonistic inhibitor of electro-mechanical coupling processes in mammalian myocardium].
Fleckenstein A; Tritthart H; Döring HJ; Byon KY
Arzneimittelforschung; 1972 Jan; 22(1):22-33. PubMed ID: 4259147
[No Abstract] [Full Text] [Related]
13. [Electromechanical uncoupling of vascular smooth muscle as the basic principle of coronary dilatation by 4-(2'-nitrophenyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (BAY a 1040, Nifedipine). 1. The significance of Ca ++ ions for the bioelectrical and mechanical activity of smooth muscle].
Grün G; Fleckenstein A
Arzneimittelforschung; 1972 Feb; 22(2):334-44. PubMed ID: 4623697
[No Abstract] [Full Text] [Related]
14. [Inhibition of adenosine uptake and stimulation of its effect on isolated hearts of warm-blooded animals by coronary active substances].
Pfleger K; Volkmer I; Kolassa N
Arzneimittelforschung; 1969 Dec; 19(12):1972-4. PubMed ID: 4985338
[No Abstract] [Full Text] [Related]
15. Coronary circulation systemic resistance and capacitance blood vessels of dogs as affected by BAY a 1040.
Hirakawa S; Ito H; Kondo Y; Watanabe I; Hiei K
Arzneimittelforschung; 1972 Feb; 22(2):344-9. PubMed ID: 4623698
[No Abstract] [Full Text] [Related]
16. Membrane effects of drugs interfering with adrenergic mechanisms.
Lemmer B; Hellenbrecht D; Grobecker H
Acta Physiol Pol; 1973; 24(1):285-8. PubMed ID: 4123752
[No Abstract] [Full Text] [Related]
17. [Efficiency of human cardiac action by coronary dilators].
Schirmer R; Hamacher J
Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):440. PubMed ID: 4253863
[No Abstract] [Full Text] [Related]
18. Effects of selective coronary hypotension and nitroglycerin or Bay a 1040 on the distribution of Rb86 clearance in the canine heart.
Nakamura M; Eto Y; Hamanaka N; Kuroiwa A; Tomoike H
Cardiovasc Res; 1973 Nov; 7(6):777-88. PubMed ID: 4206541
[No Abstract] [Full Text] [Related]
19. The effectiveness of lidoflazine and other coronary vasodilators after oral administration in the trained non-anesthetized dog.
Jageneau A; Schaper W
Arzneimittelforschung; 1967 May; 17(5):582-7. PubMed ID: 4969448
[No Abstract] [Full Text] [Related]
20. [Clinical pathophysiological studies on coronary circulation. 3. The effects of so-called coronary vasodilator agents on coronary circulation in various diseases].
Osugi S
Jpn Circ J; 1971 Feb; 35(2):268-80. PubMed ID: 5109720
[No Abstract] [Full Text] [Related]
[Next] [New Search]
